A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Acne Vulgaris
Interventions
DRUG

JNJ 10229570-AAA 1.2%

One single application of 2.5 mL of the cream will be applied to the face, neck, shoulders, chest and to the upper back areas.

DRUG

JNJ 10229570-AAA 3.6%

One single application of 2.5 mL of the cream will be applied to the face, neck, shoulders, chest and to the upper back areas.

DRUG

Color-matched vehicle containing 0 mg of JNJ 10229570-AAA

One single application of 2.5 mL of the color-matched vehicle will be applied to the face, neck, shoulders, chest and to the upper back areas.

Trial Locations (2)

Unknown

Fukukoka

Hakata

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY